Back
Corvus Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$7.42
Seasonality Move:
-12.5%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing slight selling pressure.
Corvus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.87 | Sell |
| 20-day SMA: | 8.34 | Sell |
| 50-day SMA: | 8.07 | Sell |
| 200-day SMA: | 5.4 | Buy |
| 8-day EMA: | 7.84 | Sell |
| 20-day EMA: | 8.11 | Sell |
| 50-day EMA: | 7.81 | Sell |
| 200-day EMA: | 4.65 | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 39.64 | Sell |
| Chaikin Money Flow: | -51766 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.94 - 8.9) | Sell |
| Bollinger Bands (100): | (5.55 - 8.31) | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals, Inc. Stock
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 7.48 while CRVS 8-day simple moving average is 7.87, which is a Sell signal.
-
The stock price of CRVS is 7.48 while Corvus Pharmaceuticals, Inc. 20-day SMA is 8.34, which makes it a Sell.
-
Corvus Pharmaceuticals, Inc. 50-day simple moving average is 8.07 while CRVS share price is 7.48, making it a Sell technically.
-
CRVS stock price is 7.48 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 5.40, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Buy
54
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Is Corvus Pharmaceuticals, Inc. a Buy or a Sell?
-
Corvus Pharmaceuticals, Inc. stock is rated a BuyThe current Corvus Pharmaceuticals, Inc. [CRVS] share price is $7.48. The Score for CRVS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Corvus Pharmaceuticals, Inc. Stock Info
Market Cap:
558.6M
Price in USD:
7.48
Share Volume:
448.6K
Corvus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
9.60
52-Week Low:
2.54
Buy
54
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Corvus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Corvus Pharmaceuticals, Inc. stock price today?The Corvus Pharmaceuticals, Inc. stock price is 7.48 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals, Inc. is not overvalued.
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 7.48 while CRVS 8-day exponential moving average is 7.84, which is a Sell signal.
-
The stock price of CRVS is 7.48 while Corvus Pharmaceuticals, Inc. 20-day EMA is 8.11, which makes it a Sell.
-
Corvus Pharmaceuticals, Inc. 50-day exponential moving average is 7.81 while CRVS share price is 7.48, making it a Sell technically.
-
CRVS stock price is 7.48 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 4.65, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals, Inc.
Is Corvus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Corvus Pharmaceuticals, Inc.
Should I short Corvus Pharmaceuticals, Inc. stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Corvus Pharmaceuticals, Inc. is a Sell
-
Corvus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 39.64, which suggest Corvus Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Corvus Pharmaceuticals, Inc. is (7.94 - 8.9), which suggest Corvus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Corvus Pharmaceuticals, Inc. is (5.55 - 8.31), which suggest Corvus Pharmaceuticals, Inc. is a Buy
* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.